Neurocognitive function in chronic hemodialysis patients  by Pliskin, Neil H. et al.
Kidney lntemationa4 Vol. 49 (1996), pp. 1435—1440
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Neurocognitive function in chronic hemodialysis patients. We admin-
istered a comprehensive neuropsychological test battery, including mea-
sures of intelligence, immediate and delayed memory, attention and
mental processing speed, language abilities, complex problem solving,
motor skills, and depression, to 16 well-dialyzed (KtlVurea = 1.46 0.24)
patients with end-stage renal disease (ESRD) and 12 age- and education-
matched medical controls. We observed no clear neuropsychological
deficits in these ESRD patients who had low average intelligence and
limited educational achievement, and hypothesize that previously ob-
served apparent deficits resulted either from very low dialysis delivery or
comparison with poorly-matched historical controls. There were signifi-
cant deficits in language ability and intelligence in ESRD patients with
higher than median scores on the Beck Depression Inventory compared
with less-depressed ESRD patients. However, this effect of depression did
not result in differences between dialysis and non-ESRD patient groups.
Neuropsychological dysfunction, including reduced mental
alertness, intellectual impairment, decreased attention and con-
centration, memory deficits, and diminished perceptual-motor
coordination has been reported in patients with end-stage renal
disease (ESRD) [1—22]. While ESRD patients on dialysis have
generally been found to perform better than nondialyzed ESRD
patients on standardized neuropsychological tests [8, 9, 11, 14, 17,
18, 21], some reports indicate that cognitive dysfunction persists in
chronic hemodialysis patients [6, 8, 11, 14, 18, 21, 23—33]. How-
ever, all but a few neuropsychologic investigations of ESRD
patients over the past three decades have failed to quantitate the
delivery of dialysis treatment. Indeed, medical standards of dial-
ysis adequacy have changed dramatically over the past several
decades [34], making it possible that many patients studied
previously were relatively under-dialyzed at the time of assess-
ment. Likewise, there has been methodological variation in
controlling factors such as patient age, education, race, duration
of disease and frequency of dialysis treatments, or temporal
relation between testing and day of dialysis [1—33]. We therefore
asked whether well-dialyzed, well-nourished and medically stable
ESRD patients had neuropsychological dysfunction in compari-
son to a demographically-matched medical control group.
Methods
ESRD patients
Sixteen patients (7 male, 9 female) with ESRD on chronic
hemodialysis were studied. All participants were of African-
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American descent with an average age of 59.8 years (range 36 to
77) and a mean educational level of 10.4 years (range 5 to 15). As
found in national data [35], ESRD in this group was predomi-
nantly due to hypertension (50% of sample) and diabetes (26%).
At the time of entry into the study, all patients had been receiving
thrice weekly high-flux hemodialysis for at least six months
duration (average = 38 months; range 6 to 84) and had negligible
residual renal function as determined by endogenous urea clear-
ance. We required patients to have stable dialysis delivery with
fractional urea clearance (Kt/V)> 1.0 for the prior six months, no
access-related problems, and the ability to routinely tolerate blood
flow adequate to achieve Kt/V > 1.4. Patients were excluded for
missing > 1 dialysis treatment per month, predialysis serum
phosphorous  7.0, or interdialytic weight gain > 3.5 kg. Patients
were likewise excluded from the study if they had a history of
unstable coronary vascular disease as evidenced by unstable
angina or known myocardial infarction, cerebrovascular disease as
reflected by new, transient or fixed neurologic deficits, or uncon-
trolled hypertension during the past six months, or collagen
vascular disease or vasculitis requiring administration of any
cytotoxic agents or glucocorticoids (at doses exceeding 10 mg
prednisone/day). Additionally, patients with refractory anemia
(hgb less than 9 g/dl) despite erythropoietin therapy and supple-
mental iron, and patients with evidence of protein malnutrition
[serum albumin <3.5 g/dl or protein catabolic rates (PCR) <0.8]
were also excluded.
Dialysis delivery
All study patients received high flux hemodialysis using a CT
190 dialyzer (cellulose triacetate, Baxter) with a dialysate flow rate
of 500 to 600 ml/min and a blood flow rate of> 300 mi/mm. The
average treatment time was three hours. Dialysis delivery was
assessed by single pool, variable volume urea kinetic determina-
tion of Kt/V [361 on a monthly basis and at the time of neuropsy-
chological testing (Theraps®, Cobe, Denver, CO, USA). PCR was
determined by iterative solution of equations of urea mass balance
[36]. Measured Kt/V in study patients was 1.46 0.24 (range =
1.16 to 2.03) and PCR was 1.07 0.23 (range = 0.8 to 1.5) at the
time of neuropsychological testing, and was without significant
change for  three months prior to study.
Medical controls
Twelve control patients (10 female, 2 male) were selected from
general medical and rheumatology clinics and matched to the
ESRD patients by age, education and race. All had chronic
medical conditions (4 osteoarthritis, 4 diabetes and hypertension,
4 rheumatoid arthritis) requiring clinic followup of at least 3 visits
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a year. None had serum creatinine  2.0 mg/dl. All exclusion
criteria noted above for selection of the hemodialysis patients
were applied in selection of the control group.
Neuropsychological evaluation
Table 1. Demographic information and neuropsychological test
performance in ESRD patients and controls
ESRD (N = 16) Controls (N = 12)
mean (SD) mean (SD) P
A comprehensive neuropsychological test battery was adminis-
tered to all participants on a single midweek, post-dialysis day
(thereby reducing the potential confounding effects of varying
Age
Education
Beck Depression
Score
59.8 (15.5)
10.4 (3.6)
12.2 (8.6)
58.7 (12.3)
11.2 (1.1)
6.0 (4.4)
NS
NS
NS
uremia). The test battery measured: (1) intelligence (Wechsler
Adult Intelligence Scale-Revised; WAIS-R) [37]; (2) immediate IntelligenceVerbal IQ 86.2 (8.9) 85.8 (9.5) NS
and delayed memory (Wechsler Memory Scale; WMS) [38]; (3) Performance 10 84.5 (11.6) 82.3 (9.2) NS
attention/mental processing speed (Paced Auditory Serial Addi- Full Scale 10 84.7 (9.5) 84.0 (9.0) NS
tion Task; PASAT, Trail Making Test, Stroop Color-Word Test) Information 8.4 (2.1) 7.1 (1.6) NS
[39—41]; (4) language abilities (Boston Naming Test, Controlled
Oral Word Association) [42—43]; (5) complex problem solving
(Tactual Performance Test, Category Test) [44—45]; (6) motOr
abilities (Finger Tapping Test) [45]; and (7) depression (Beck
Depression Inventory; BDI) [46].
Digit Span
Vocabularl'
Arithmetic
Similarities
Picture Compl.
Picture Arr.
7.7 (2.0)
8.1 (1.8)
7.1 (1.9)
8.1 (2.0)
7.9 (3.4)
8.8 (2.5)
8.3 (2.2)
7.4 (2.0)
8.0 (1.9)
7.8 (2.6)
6.8 (2.0)
7.3 (1.6)
NS
NS
NS
MS
NS
NS
Data analysis
Block Design
Obj. Assembly
7.5 (2.3)
6.6 (2.0)
6.6 (3.0)
7.6 (1.9)
NS
NS
Data are presented as means and sDs. Neuropsychological test Digit Symbol 6.6 (2.0) 7.6 (1.9) NS
scores were corrected for age and education where published Memory
norms allowed, so as to permit comparison between groups.
WAIS-R intelligence quotients (IQs) were standard scores (mean
= 100, SD = 15) with age-corrected subtest scores (mean = 10, SD
= 3). Age- and education-corrected T-scores (mean = 50, 5D =
Wechsler Memory Scale:
Memory Quotient
Immediate Verbal
Delayed Verbal
Verbal % Retained
100.3 (15.2)
17.7 (5.7)
14.7 (5.5)
87.0 (15.9)
98.8 (13.0)
17.8 (6.6)
15.6 (5.9)
89.8 (13.1)
NS
NS
NS
NS
10) or standardized Z-scores (mean = 0, SD = 1) were computed
for the Stroop, PASAT, Boston Naming Test, Trailmaking Test,
Category Test, Tactual Performance Test, Grip Strength and
Finger Tapping Test [47, 48]. Age-corrected raw scores were
reported for the Wechsler Memory Scale [9I. Analysis of van-
ance (ANOVA) was utilized to analyze differences between group
Immediate Visual
Delayed Visual
Visual % Retained
Attention/mental processing
speed
PASAT (Z-Score)
Trial 1
6.9 (3.3)
5.7 (3.1)
80.6 (27.2)
—2.1 (.83)
6.5 (3.3)
5.3 (2.4)
88.4 (37.4)
—1.5 (.97)
NS
NS
NS
MS
means, with P values, uncorrected for multiple comparisons, Trial 2 —1.8 (.78) —1.4 (1.0) NS
considered significant if  0.05. Analysis of the relationship
between depression and neuropsychological performance in
Trial 3
Trial 4
—1.4 (.60)
—1.0 (.63)
—1.1 (.56)
—0.9 (.57)
NS
NS
ESRD patients was accomplished by determining the median
Beck Depression Inventory score and utilizing ANOVA, with F
tests to compare ESRD patients above and below the median with
results reported at P  0.05.
Stroop (T-Score)
Word
Color
Color-Word
Trailmaking (T-Score)
32.2 (7.3)
31.3 (10.8)
35.6 (7.2)
38.2 (5.7)
39.2 (6.4)
35.2 (8.8)
0.03
0.04
NS
Results Part APart B
37.3 (8.7)
35.5 (6.5)
36.1 (7.6)
35.0 (10.9)
NS
NS
Demographic characteristics and neuropsychological perfor-
mance in ESRD patients and medical controls are presented in LanguageBoston Naming Test
—3.2 (2.7) —4.4 (5.9) NS
Table 1. By design, there were no differences in age or education (Z-Scores):
between ESRD patients and medical controls. Intellectual func-
tion likewise did not differ between groups, falling in the Low
Word Fluency:
Aphasia Screen Test:
36.8 (7.6)
43.4 (12.2)
33.8 (10.7)
46.3 (14.1)
MS
MS
Average range (mean Full Scale JO for both groups = 84), which
was not unexpected given the groups' level of educational attain-
ment. Measures of memory, language and complex problem-
solving also did not differ between groups. The Stroop Word (P
Complex problem solving
Tactual Performance Test
(T-Scores):
Dominant
Nondominant
37.3 (11.2)
36.6 (8.0)
42.2 (8.5)
40.2 (3.8)
NS
NS
0.03) and Color reading (P 0.04) tests suggested decreased
attention/mental processing speed in ESRD patients. By contrast,
performance on other attention- and speed-demanding tasks
(Trailmaking Test, PASAT, Stroop Color-Word condition) did
Both Hands
Total Time
Memory
Location
Category Test: (T-Scores)
40.2 (6.7)
38.5 (9.0)
39.2 (7.0)
44.7 (6.5)
35.6 (7.9)
40.6 (5.8)
41.4 (6.0)
35.8 (8.0)
41.0 (6.4)
35.0 (9.1)
MS
MS
MS
NS
MS
not differ between groups. Grip Strength was worse bilaterally in
ESRD patients (P 0.0001), while there were no differences in Motor skills Finger Tapping(T-Scores):
Finger Tapping speed. Depression self-rating (BDI score), ap- Dominant 37.3 (8.8) 38.6 (8.1) MS
peared slightly higher in ESRD patients, but did not differ Nondominant 35.9 (9.7) 36.1 (9.3) MS
significantly from that in controls. Grip Strenth (T-Scores):
To determine if those ESRD patients with higher levels of
depression demonstrated greater neuropsychological deficits,
Dominant
Nondominant
35.7 (7.5)
38.1 (8.8)
52.3 (6.6)
55.1 (6.8)
0.0001
0.001
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patients were split into two groups, above and below the median
BDI score of 13.5. One group had a mean BDI score of 18.4
(median = 15, range = 14 to 30, N = 8), while the other had a
mean BDI score of 6.1 (median = 6.5, range = 0 to 13, N = 8).
Comparison of these two groups revealed significant differences in
intelligence scores on Full Scale 10 [F (10,14) = 4.39, P < 0.051
and Verbal 10 [F (1,14) = 5.59, P < 0.031 including Digit Span [F
(1,14) = 4.98, P < 0.041 and Comprehension [F (1,14) = 6.95, P
< 0.02] subtests, as well as language abilities [Verbal Fluency
Total Score; F (1,14) 4.39, P < 0.05], with the less-depressed
ESRD patients scoring consistently better on all of these mea-
sures. With the exception of the composite Memory Quotient of
the WMS [F (1,14) = 12.06, P < 0.0041; however, no other
significant differences in memory, attention/processing speed,
complex problem-solving or motor skills were noted between
more-depressed and less-depressed ESRD patients (Table 2).
Discussion
Both chronic renal failure and chronic dialysis are thought to be
associated with neuropsychological impairment, including selec-
tive deficits in verbal and nonverbal abilities, confusion, decreased
attention and concentration, decreased mental alertness, fluctu-
ating memory and reduced visuomotor integration and abstract-
ing ability [1—33]. In chronic renal failure, these neurobehavioral
symptoms appear to worsen with progressive uremia [50]. Neuro-
psychological status improves following institution of dialysis [8,
18, 23, 24, 28] and dialysis patients have less cognitive impairment
compared to untreated patients with advanced uremia [14, 17, 18,
20, 211. However, cognitive dysfunction, including reduced con-
centration capacity, learning and memory, as well as cognitive
inflexibility and impaired complex novel problem solving, is
commonly reported to persist in dialysis patients [6, 8, 11, 14, 18,
21, 23—33]. Importantly, these findings of persisting deficits derive
from studies which rarely employed the same measure(s) of
neuropsychological functioning or similar experimental design.
Moreover, many studies utilized small samples [1, 2, 4, 5, 12, 13,
18, 19], examining only specific areas of function such as intelli-
gence [2—6, 12, 13, 25], attention [26] or memory [27]. Many of
these studies failed to address demographic factors relating to
race [1—33] and education [2, 5—9, 24—26, 30, 32], nor were
important issues such as duration of disease [4—6,9, 12, 22—26, 321
or the temporal relationship between testing and day of dialysis [4,
6—9, 12—14, 16, 23] reported. While some studies, particularly
those examining the impact of dialysis on the effects of untreated
uremia [8, 181 or disequilibrium before or after dialysis, used
within-subject comparisons [23, 24, 29], by design they were not
constructed to allow definition of those deficits that persist with
stable dialysis when compared to normal controls. Additionally,
we now recognize that many comorbid conditions which are
common in ESRD patients (such as coronary artery disease,
uncontrolled hypertension, cerebrovascular disease, diabetes and
depression) can also contribute to neuropsychological dysfunction
1511. Yet, many prior studies failed to consider these relevant
medical or psychiatric comorbidities in the interpretation of test
findings [1, 2, 4, 6, 8, 9, 12, 19, 20, 21, 23—28, 32—33]. Thus, while
most would accept the concept of persisting specific neuropsycho-
logical deficits in dialyzed ESRD patients, support of this belief
rests upon studies in which there are considerable methodological
variations, inadequate accounting for potential confounding fac-
tors, and inconsistency of conclusions.
Most prior neuropsychological studies were not global in na-
Table 2. Means and standard deviations for higher versus lower
depression ESRD patients
High Low
Mean SD Mean SD
Intelligence
Verbal ja
Performance 10
Full Scale IQ
Information
Digit Spana
Vocabulary
Arithmetic
Comprehension'
Similarities
Picture Completion
Picture Arrangement
Block Design
Object Assembly
Digit Symbol
Memory
Wechsler Memory Scale
Memory Quotienta
Immediate Verbal
Delayed Verbal
Verbal & Retained
Immediate Visual
Delayed Visual
Visual % Retained
Attention/mental processing speed
Paced Auditory Serial Addition Task
Trial I
Trial 2
Trial 3
Trial 4
Stroop:
Word
Color
Color-Word
Interference
Trail Making Test
Part A
Part B
Language
Boston Naming Test
Verbal Fluencya
Aphasia Screening Test
Complex problem solving
Category Test
Tactual Performance Test
Dominant
Nondominant
Both Hands
Total Time
Memory
Motor Skills
Finger Tapping
Dominant
Nondominant
Grip Strength
Dominant Hand
Nondominant Hand
a P < 0.05
81.62 4.69 90.88 10.02
79.88 7.12 89.25 13.80
80.25 4.92 89.25 11.11
7.38 1.06 9.5 2.56
6.75 2.05 8.75 1.49
7.38 1.30 8.88 2.17
7.50 1.77 8.75 1.75
6.12 1.64 8.25 1.58
7.38 1.59 9.00 2.20
6.88 2.53 9.00 4.11
8.50 1.85 9.25 3.11
6.75 1.39 8.25 2.96
6.12 2.29 7.62 2.33
5.75 1.39 7.62 2.33
90.25 10.69 110.38 12.42
16.38 4.94 19.19 6.43
13.38 5.06 16.06 6.03
0.85 0.18 0.88 0.15
5.88 3.09 8.00 3.51
5.00 3.29 6.50 3.02
0.87 0.18 0.74 0.34
15.38 12.15 20.12 6.24
14.62 8.83 17.25 6.94
11.25 7.70 12.88 7.81
9.00 6.44 10.50 8.05
66.88 13.04 78.38 15.16
46.12 11.21 54.00 24.15
28.62 8.18 32.25 6.34
1.75 10.62 1.04 10.78
73.50 40.52 63.62 30.02
297.62 299.24 237.00 209.78
37.12 15.22 44.12 15.42
31.38 5.48 42.38 5.07
12.88 10.25 6.00 4.50
87.00 40.08 103.25 13.31
2.79 2.23 1.74 0.97
3.01 3.89 1.66 0.93
1.10 0.95 1.51 1.08
1.85 1.60 1.42 0.59
4.33 3.08 4.62 2.26
33.5 12.35 35.05 11.03
31.48 8.36 31.73 6.99
25.05
24.92
12.49
10.61
25.94
20.78
9.76
6.27
ture, and thus it is not clear which specific function(s) might be
impaired in ESRD patients on dialysis. We hypothesized that
deficits might appear in a specific cognitive sphere, although we
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had no clear, consistent basis to decide where. Therefore, we
assessed neuropsychological function in detail, using measures of
intelligence, attention/mental processing speed, memory, lan-
guage function, motor skills and complex problem solving. We
used multiple measures in assessing these neuropsychologic do-
mains so that we wouldn't overinterpret findings based on single
tests. Importantly, we selected a control group that was well
matched for important demographic variables, including age and
level of education. We carefully excluded patients with medical
comorbidities such as unstable coronary or cerebrovascular dis-
ease, new or fixed neurologic deficits, refractory anemia, malnu-
trition or active collagen vascular disease.
We found no differences between dialysis patients and demo-
graphically-matched controls using measures of general intellec-
tual function, memory, language abilities or complex problem-
solving. Indeed, both groups demonstrated low average intelligence
with mildly impaired neurocognitive function. Whether our results
discussed below would have occurred in a group with an overall
higher level of intellectual function is unknown. The one notable
difference in performance between groups was on the Stroop Test,
a measure of sustained attention and mental processing speed,
where ESRD patients performed more poorly in two of the three
test conditions (Word and Color), although both groups still fell in
the low average range. Since the Word and Color conditions of
the Stroop test assess mental processing speed by asking subjects
to rapidly read words and to identify the color of ink as it appears
on a page, and the Color-Word condition is more sensitive to
distractibility by requiring subjects to read the name of a color
printed in ink of a different color, we interpret the lack of
difference between groups on the Color-Word condition to sug-
gest that dialysis patients have slowed mental processing speed
without overt distractibility. By contrast, there were no differences
on other measures of attention/processing speed, including the
Trailmaking Test, which has been commonly reported to be
impaired [9, 10, 14, 19], and the more highly demanding and
sensitive PASAT. We can't help but notice that while two
independent tests of attention/processing speed failed to detect
any impairment in the ESRD group, two of three Stroop condi-
tions were worse in the ESRD group. Further studies of attention
using other measures of attention/processing speed may shed light
on this apparent, albeit limited contradiction. We did not adjust P
values for multiple comparisons, which would have negated the
significance of the Stroop test differences, because we did many
tests without a clear basis to know which cognitive spheres might
be selectively impaired. Had a prior consistent literature allowed
us to focus on specific tests, we would have designed this study
accordingly. However, by reporting uncorrected P values, we had
greater certainty that we would not overlook any potential find-
ings and could therefore facilitate future studies by labeling those
spheres of potential significance in our population.
ESRD patients had relatively impaired gross motor function,
assessed by Grip Strength. Results were similar for dominant and
nondominant hands and may have resulted from undiagnosed
joint dysfunction, muscle weakness due to electrolyte abnormality,
subtle nutritional deficits, or deconditioning. However, these
decrements in gross motor strength have no apparent implications
for subtle neuropsychological impairment associated with uremia.
ESRD patients reported more symptoms of depression on the
Beck Depression Inventory (mean 12,3, median 13.5, range 0 to
30) than did controls (mean 4.3, median 3, range 0 to 10),
although the difference between groups was not statistically
significant. It is important to note that this self report instrument
also assesses multiple somatic complaints and may, as a result,
over-diagnose depression in more medically ill patients. There-
fore, while the significance of this finding is not clear and we did
not confirm the degree of depression by a standardized interview,
it supports a role for such case-finding tools as the BDI in
screening for clinically unrecognized depression [52]. If the ESRD
patients were suffering from greater clinical depression, then we
might have expected them to perform more poorly than controls
on many of the neuropsychological measures, which they did not.
When ESRD patients with higher than median BDI scores were
compared with those falling below the median, no significant
differences in memory, attention/processing speed, complex prob-
lem-solving or motor skills were noted between groups. Thus,
while depression appeared to impair performance in a number of
cognitive spheres, as expected, it had no effect on these areas
which have previously been thought to be sensitive to uremia.
Early cognitive studies of dialyzed ESRD patients are uninter-
pretable, since they failed to quantify dialysis delivery or ensure
the minimal dialysis prescription suggested by results of the
National Cooperative Dialysis Study. Therefore, neuropsycholog-
ical deficits reported previously may have been directly related to
variable and inadequate levels of dialysis rather than due to
ESRD per Se. In fact, we could find only a few neuropsychological
studies of dialysis patients that actually reported dialysis prescrip-
tion via urea kinetic modeling [30, 32, 33, 53]. Marsh and
colleagues [31] found that dialysis patients receiving Kt/V of 1.0 to
1.2 demonstrated borderline impaired mental processing speed
and low average verbal learning and memory. Wolcott [30]
compared chronic ambulatory peritoneal dialysis patients, in
whom dialysis delivery was not measured, to hemodialysis pa-
tients, who achieved a Kt/V of 0.8 to 1.2. They found that
peritoneal dialysis patients consistently performed better, al-
though both groups always performed "less well than historical
controls." We cannot conclude whether differences between he-
modialysis and peritoneal dialysis patients were due to differences
in dialysis delivery, dialysis modality, or a selection bias in the
choice of dialysis modality. Churchill and colleagues [53] exam-
ined quality of life and cognitive measures in dialysis patients with
stable Kt/V > 1.0 compared to dialysis patients who were initially
under-dialyzed (Kt/V < 0.8). Dialysis delivery in the inadequately
dialyzed group was immediately increased to Kt/V of 1.0 and both
groups repeated some tests after six to eight weeks. No systematic
neuropsychological changes were reported between the stable
versus improved dialysis groups after six to eight weeks, although
these data were not presented. Churchill [33] later compared high
flux hemodialysis (Kt/V 1.41) with conventional dialysis (Kt/V
= 1.27) using a battery of multiple neuropsychological tests in 22
patients in a single crossover, random allocation design. No
statistically significant improvement in neuropsychological func-
tion was demonstrated with high flux dialysis. However, compar-
ison of results of these dialysis patients with historical adult norms
again suggested neuropsychological deficits more traditionally
attributed to ESRD patients. Our results demonstrate mild neu-
rocognitive deficits, similar to those observed by Wolcott [30] and
by Churchill [33]. However, comparison with a demographically
matched, concurrent (rather than normative historical) control
group allowed us to conclude that these deficits were not due to
uncorrected uremia.
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Clearly inadequate dialysis delivery results in worsening of
EEG measures of brain activity and prospectively decreasing
dialysis delivery from KtIV = 1 to KtIV < 0.7 likewise impaired
some measures of neurobehavioral function [54]. Conversely,
restoration of normal renal function by transplantation in 9
hemodialysis patients significantly improved abnormalities in the
EEG power spectrum, such that it did not differ from values in
normal controls [55]. While no comprehensive neuropsychologic
evaluation was performed in this latter study, it is possible that
electrophysiological methods may better detect clinically silent
residual uremia than neuropsychological testing [561.
While current standards of dialysis prescription should avoid
the neuropsychological impairment suggested by Teschan, many
patients with low dialysis delivery in spite of adequate dialysis
prescription may still be at risk for such uremic dysfunction. More
recently, improved morbidity and mortality have been reported to
result from enhanced dialysis delivery (Kt/V > 1.4) [57]. The
benefit of such increased dialysis is currently the subject of a large
multicenter investigation which does not include neuropsycholog-
ical outcome measures. Our ESRD patient group received dialysis
delivery in excess of that usually considered adequate in North
America, but delivery did not either meet or exceed levels
associated with improved long-term survival in some European
centers [571.
We observed no clear neuropsychological deficits in our well
dialyzed (KtIV = 1.46 0.24) ESRD patients compared with
demographically-matched controls. We hypothesize that previ-
ously observed deficits resulted from very low dialysis delivery or
invalid comparison with (poorly matched) historical controls.
Whether there is a continuous dose-response relationship dem-
onstrating progressive resolution of neuropsychological deficits as
a function of increased dialysis delivery at values of KtIV in excess
of 1.0 remains to be determined. Alternatively, it is possible that
most neuropsychologie deficits resolve at some threshold value of
dialysis adequacy and there is little improvement with further
increases, short of restoring normal renal function by transplan-
tation. Finally, we cannot comment on whether a dialysis popu-
lation of different demographic makeup, with a higher level of
intellectual function and greater educational background, might
demonstrate persistent subtle deficits in comparison to their
appropriate control group. We can, however, conclude that for
this study population, when providing this level of renal replace-
ment therapy, there arc no persistent neuropsychological deficits
related to uremia.
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